United States · FDA National Drug Code directory
CIMERLI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61314-624_0bfab18c-289a-42a1-b426-0fc2274a7a3e
- Product NDC
- 61314-624
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ranibizumab-eqrn
- Labeler
- Sandoz Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20241212
- Source listing expiry
- 20261231
Source-listed ingredients
- RANIBIZUMAB — .3 mg/.05mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (61314-624-94) / .05 mL in 1 VIAL, SINGLE-DOSE · 61314-624-94
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →